General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
LLY Should Find Support In Pullbacks | news.google.com • |
LLY Should Find Support In Pullbacks | news.google.com • |
LLY Should Find Support In Pullbacks | news.google.com • |
Eli Lilly and Company (NYSE:LLY) Stock Price Down 0% After Insider Selling | news.google.com • |
Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) | seekingalpha.com • |
Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript) | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-30 | 2024-03 | 2.53 | 2.58 | 0.05 | 1.98% |
2024-02-06 | 2023-12 | 2.47 | 2.49 | 0.02 | 0.81% |
2023-11-02 | 2023-09 | -0.08 | 0.1 | 0.18 | 225.00% |
2023-08-08 | 2023-06 | 1.98 | 2.11 | 0.13 | 6.57% |
2023-04-27 | 2023-03 | 1.73 | 1.62 | -0.11 | -6.36% |
2023-02-02 | 2022-12 | 1.83 | 2.09 | 0.26 | 14.21% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-10-08 | Wells Fargo | Upgrade | Overweight | Overweight |
2023-10-08 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-10-01 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-04 | Morgan Stanley | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-05-19 | ALVAREZ RALPH | Director | 54.04K | Stock Award(Grant) |
2024-05-19 | HEDLEY MARY LYNNE | Director | 1.59K | Stock Award(Grant) |
2024-05-19 | JOHNSON KIMBERLY H | Director | 2.64K | Stock Award(Grant) |
2024-05-30 | LILLY ENDOWMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 98.40M | Sale |
2024-05-19 | LUCIANO JUAN R | Director | 15.70K | Stock Award(Grant) |
2024-06-02 | NORTON JOHNA L | Officer | 27.73K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | Lilly Endowment, Inc | 99.98M | 53.70B | 10.53% |
2023-06-29 | Vanguard Group Inc | 69.92M | 32.79B | 7.37% |
2023-06-29 | Blackrock Inc. | 64.45M | 30.23B | 6.79% |
2023-06-29 | PNC Financial Services Group, Inc. | 51.87M | 24.33B | 5.46% |
2023-06-29 | State Street Corporation | 33.88M | 15.89B | 3.57% |
2023-06-29 | FMR, LLC | 32.80M | 15.38B | 3.46% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 26.65M | 12.50B | 2.81% |
2023-06-29 | Vanguard 500 Index Fund | 18.76M | 8.80B | 1.98% |
2023-06-29 | Vanguard/Primecap Fund | 13.35M | 6.26B | 1.41% |
2023-05-30 | Fidelity 500 Index Fund | 8.83M | 3.79B | 0.93% |
2023-08-30 | SPDR S&P 500 ETF Trust | 8.68M | 4.81B | 0.91% |
2023-08-30 | iShares Core S&P 500 ETF | 7.37M | 4.08B | 0.78% |
Dividend | Date |
---|---|
1.3 | 2024-05-15 |
1.3 | 2024-02-15 |
1.3 | 2024-02-14 |
1.13 | 2023-11-14 |
1.13 | 2023-09-08 |
1.13 | 2023-08-14 |
Split | Date |
---|---|
2 : 1 | 1997-10-16 |
2 : 1 | 1995-12-21 |
2 : 1 | 1989-05-01 |
2 : 1 | 1986-01-30 |
nothing ahead.
1500 stock price would be 2T mkt cap for a drug company.
your pumping
$LLY Best of Breed. $1,500 end of year. Big things ahead!
$LLY Best of Breed in Many Things..
huge gaps 672 and 472… theyll fill.
this thing is doomed. look at that chart. Maxed out on every timeline available.
“calls here” lol stfu.
$LLY Best Of Breed. See ya at $1,000 Soon!!
$LLY Best of Breed. Top in Weight Loss, Liver Disease, Diabetes, Alzheimer’s and more.
Next Trillion Dollar Company..
$LLY BEST OF BREED PERIOD !!!
$LLY On sale here. Oversold on bad info.
Amgen will need 3 years to get to market.
Lilly has best of breed with a pill coming.
They also will own the market in Alzheimer’s, liver, disease, diabetes, and others.
$1,500 this year.
$LLY Amgen won’t make a cent for years.
Incredibly Undervalued Here. $1,500 eoy
$LLY Best Of Breed Period. Weight Loss, Alzheimer’s, Liver Disease, Diabetes. These are
all Multi Billion Drugs close to approval.
$2,500 in 2 years.
$LLY Amgen is years away with no approvals.
People are stupid and overreacting. Sales here are exploding with several other high value drugs ready for approval and people are selling???
I am buying these dips. See you at $1,200+ eoy
$LLY Laughably Undervalued Here.
BEST OF BREED PERIOD
$LLY Screaming Buy. Best of Breed Period.
https://www.fool.com/investing/2024/05/02/heres-why-eli-lilly-stock-remains-a-screaming-buy/